Weekly - Bullish Conservative Investors - Go To TTD Long-Term Plays - Monday, March 9, 2020 |
Go to Video Show - "How to Make Money With Breakout Stocks |
---|
By Leo Fasciocco -- TTD
Ticker Tape Digest presents its daily stock market report containing stocks to go long as Breakout Trades, Quick Trades, or Bargain Accumulation Trades.
We also feature stocks under Significant Accumulation that are poised to breakout.
Ticker Tape Digest's Daily schedule guide for TTD subscribers 1. Pre-market - check Breakout Watch List and Quick Trades. 2. Morning - (11:30 - 12 A.M.) - check breakout stocks tape and breakout chart slide show. 3. Midday (1 P.M.) check TTD Midsession Report and see market video show. 4. After close (4 P.M.) check final TTD Report for day. Trading Strategies Bullish Aggressive Investors Bullish - "Breakout Stocks" - ideally suited for bull markets and special situation stocks. Potential for large returns. (See Performance) Aggressive Investor Bullish- "Quick Trade Stocks" -ideally suited for entry into top performing issues looking for a small quick profit." (See Performance) Conservative Investors "Bargain Buy Trades for the Long Term." Ideally suited for entry into top performing big cap stocks on pullbacks within overall up trend.(See Performance) Bearish Aggressive Bearish Investors - "Breakdown Stocks" to Sell Short. Ideally suited for bear markets or market pull backs. Potential for large returns (See Performance) |
---|
The TTD report also contains stocks to short as breakdown plays and as bargain (swing trade) shorts.
Investors should tend to try to go with a strategy that fits with the stock market's trend, unless there is a special situation play.
TTD's Breakout Stocks - Long are most suitable for aggressive investors seeking ideal entry points into leading stocks, especially during bull markets. They can do extremely well in bull markets with gains of as much as several hundred percent.
These stocks can also do extremely well during strong market rallies, or if they are in a industry group that is performing very well. They tend to have strong earnings outlooks and are near new-52 week, or all-time highs.
TTD Quick Trade Stocks - Long These are leading issues that have pulled back in recent days, but could move higher soon. They are most suitable for Aggressive Investors willing to trade short term. These stocks will do extremely well during market advances. They have about 74% win rate. During market rally sequences the win rate is even higher. The return is small 3% to 8% in just a few days.
TTD's Bargain Buy Trades - Long - Long Term. These are for conservative bullish Investors These long-term buys are ideally suited for entry into stocks on pull backs within overall up trend. These stocks can give a good return long-term especially during a bull market.
TTD also presents Stocks To Sell or Sell Short. These issues are suitable for aggressive investors willing to take short positions both as trades or for longer-term plays. These stocks will do very well during bear markets or market pull backs.
TTD's Bearish breakdown stocks to sell short. These issues have potential to fall sharply. They often show a technical breakdown and also some fundamental business problem such as weak earnings.
TTD's multi-media updates include a slide-show that presents charts and analysis at midsession. Some times TTD presents feature analysis on stocks and the market. TTD uses Windows Media Files. (WMV).
TTD also presents a "Breakout Watch List" that is up dated daily. This list consists of key stocks in position to breakout. A close watch of this list can put you in the stock just as it breaks out. A good idea is to study the list and be ready to move into a stock quickly as it hits its breakpoint.
TTD often suggests using stop buy orders to enter. It is very important to buy a breakout stock as close as possible to the breakpoint. The idea is to get "elbow room" if the stock should follow through to the upside. This is very important in being successful in making big money with breakout stocks.
It is also essential to have a stop loss strategy for all stocks in which positions are taken. Not every stock will work as expected. It is important for investors to "police" their portfolios and avoid getting trapped in any bad positions.
Quality rating of breakout Two key factors: 1 - Stock near all-time high in price or near a 52-week high. 2 - earnings growth current year is strong. The ideal play is a stock with an Above Average Quality Rating. The stock is near a new high and will have strong earnings. TTD's other ratings are Average and Below Average.
TTD also has special feature sections on Educational Tips on Investing.
To email Mr. Leo Fasciocco leo@tickertapedigest.com.
For service, email Beverly Owen owen@tickertapedigest.com. TTD’s Tel: 1-480-878-8381 or 480-704-3331.
Tuesday - March 10, 2020
TTD's Breakout Stocks
Stock Market Overview
Total Buy Breakouts Tuesday - 1
Quality of Breakouts - Below Average.
Stocks Screened - 12,234
Bull side - Only one breakout. Bulls be conservative.
Stock market - Stock market rallies strongly. However, major averages remain bearish daily and weekly. The monthly averages are bearish, except for the Nasdaq.
Comment - Stock market has a key reversal day. What is needed is a pause and then another rally day of 1% with volume. Look for that.
See Latest Earnings Reports - A company that tops the Street's highest earnings estimate has potential to go higher. Key earnings beats - BBX, CLDR, IEA, III, DKS and KFY.
Stock Market Momentum
(Daily is based on a moving average)
Market (Daily) |
Market (Weekly) |
Market (Monthly) |
Dow - Bearish |
Dow - Bearish |
Dow - Bearish |
Nasdaq - Bearish |
Nasdaq - Bearish |
Nasdaq - Bullish |
S&P 500 - Bearish |
S&P 500 - Bearish |
S&P 500 - Bearish |
TTD's Quality Rating of Stock - CGEN - BELOW AVERAGE |
CGEN, based in Israel, is a therapeutic drug discovery company. CGEN's stock spikes higher Tuesday on news of favorable results for a drug to treat cancer. Annual revenues: Nil.
So far today, CGEN is trading a heavy 3.2 million shares, four times its average daily volume of 818,000 shares.
CGEN is a speculative play. However, TTD does see potential for a move higher. It is only suitable for very aggressive bulls.
CGEN's stock rose sharply in the morning and cleared its breakpoint line.
The stock reached an intraday high of $12.80 in the morning.
The stock then backed off slightly and trended mostly sideways the rest of the day.
Tape Action
CGEN's tape action shows the price for the blocks climbing from $9.92 in the prior session to as high as $12.25 in the afternoon.
A key bullish trade came late on Monday when a block of 10,140 shares (duplicated) crossed the tape at $10.01.
That was up from the prior block at $9.92 on 11,900 shares on Monday.
Late in the day a block of 15,385 shares crossed at $11.80.
That came on a down tick from the prior trade at $11.81 on 100 shares.
Business
CGEN develops therapeutic and product candidates.
CGEN's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by its primarily immune checkpoint and myeloid protein target candidates.
These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in unmet medical needs in various cancer patients.
Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology.
Charts
CGEN's 12-month performance chart shows the stock up 240% versus a 1% gain for the stock market.
Insider activity was not available.
CGEN's long-term chart shows the stock climbing from $3 back in 2012 to a peak at $14.32 by 2014.
However, the stock drifted back to $2.25 by 2017. It formed a bottom and has since driven sharply higher since 2019.
CGEN's daily chart shows the stock working higher from $4 back in October to a peak near $10 by February.
The stock formed a base with a breakpoint zone.
Tuesday, it blows out of the base with a big pick up in volume.
The stock's CCI momentum indicator is strongly bullish.
Earnings Outlook
This year, analysts are forecasting a loss of 45 cents a share compared with a loss of 43 cents the prior year.
Looking out to 2021, the Street sees a loss of 50 cents a share.
For the upcoming first quarter, analysts expect a loss of 11 cents a share compared with a loss of 14 cents the prior year.
Then in the second quarter they see a loss of 11 cents a share compared with a loss of 10 cents the previous year.
Three analysts track the stock.
Strategy Opinion: TTD is targeting CGEN for a move to $14 within the next few months, or sooner.
A protective stop can be placed near $11.40.
Intermediate-Term Rating: Below Average.
Suitability: Aggressive Bulls.
TTD's special research of Stock's Prior Performance:
Breakout Success |
Bullish |
CGEN scored big gains off recent breakouts. |
Response to Net |
Bullish |
CGEN rose 8 times after 15 earnings reports. |
Seasonal Success |
Bullish |
CGEN avg. gain 15.7% in March., loss 5.3% in April prior years. |
Earnings Beats |
Bullish |
CGEN beat Street net estimate 7 times after 10 reports. |
Stock's Prior Performance After A Breakout
Stock's % Change from Breakout to peak - prior to cut below 50-day M/A. |
Date of Breakout |
Break point Price |
Stocks Price Peak after Breakout - prior to cut below 50-day M/A |
Date Trade Closed |
86% |
1/23/2020 | 6.27 | 11.64 | Still in play |
165% |
10/29/2019 | 4.38 | 11.64 | Still in play |
63% |
12/31/2013 | 6.50 | 10.60 | 10/23/2013 |
(In actual trading, entry and exit points could vary depending on broker execution.
Also, ideal are breakouts to a new 52-week high or better, perhaps all-time highs.)
Stock's Long-term Chart
Stock's Price Performance after Reporting Earnings
Stock's Performance Chart with Quarterly Earnings Markers vs. S&P 500
Insider Buying in Green - Insider Selling in Red
Ticker Tape Digest’s Daily List of “Stocks To Sell or Sell Short” ranks stocks well timed to be sold immediately based on daily trading. The list can be used as an alert to reduce current long-term positions.
Shorts from tape action for Thursday - 7
Stocks Screened - 12,234
Long-Term Environment for bears: Neutral.
Bear Side - Small list of shorts Tuesday as stock market rallies after recent big selloff. Bears be selective.
VIVO, based in Cincinnati, Ohio, makes test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels. Annual revenues: $201 million. VIVO's stock falls sharply Tuesday and undercuts key technical support.
So far today, VIVO is trading 1.2 million shares. Its average daily volume is 839,000 shares.
TTD sees more on the downside.
VIVO's stock declined in the morning and undercut key technical support.
The stock continued to trend lower finally hitting a bottom in the afternoon at $6.61.
It lifted late in the day as the stock market rallied.
Tape Action
VIVO's tape action shows the recent block trades.
One can see the price for the blocks falling from $7.77 in the morning to as low as $6.70 in the afternoon.
A key bearish trade came in the morning when a block of 10,946 shares crossed the tape at $7.30.
That was down from the prior block at $7.43 on 7,800 shares.
Business
VIVO makes and sells diagnostic test kits for medical use.
It also produces bulk antigens, antibodies, polymerase chain reaction
The company sells its diagnostic test kits in North, Central and South America; Europe, the Middle East and Africa.
Earnings:
Net for the fiscal year ending in September are projected to fall 49% to 35 cents a share from the 68 cents the prior year.
Net for the first quarter is projected to fall 58% and then in the second quarter tumble 63%.
Charts:
VIVO's daily chart shows the stock trending lower since January when it peaked at $13.31.
VIVO's 12-month performance chart shows the stock down 55% versus a 2% gain for the stock market.
Strategy Opinion: TTD is targeting VIVO for a decline to $5.40. A protective stop buy can be placed near $7.50.
Suitability: Aggressive Bears.
TTD's Stock Probability research of Prior Performance:
Response to Net |
Bearish |
VIVO rose 6 times after 15 earnings reports. |
Seasonal Success |
Bearish |
VIVO rose 0.1% in March, fell 8% in April in prior years. |
Earnings Beats |
Neutral |
VIVO beat Street estimate 10 times after 20 reports. |
TTD's Quality Rating of Stock - VIVO - BELOW AVERAGE |
Stock's Performance Chart with Quarterly Earnings Markers vs. S&P 500
Insider Buying in Green - Insider Selling in Red
TTD columnist Leo Fasciocco has covered the stock market for over 30 years. His articles appear in many publications. He has also been a speaker at the Money Show conferences. He has been on television and radio. He is author of many educational articles about stock investing and the book “Guide To High-Performance Investing.”
For information to subscribe to the Ticker Tape Digest Services call: Beverly Owen at 1-480-878-8381.
Distributed by Corona Publishing Enterprises. TickerTape Digest Inc. 1220 W. Sherri, Gilbert, Az. 85233.
TTD “Professional Report” is available on the Web: $100 per month. Password needed. Published daily - around 20 times a month.
TTD Pro Report includes a Morning chart slide show of breakout stocks, a Midsession video-audio show with commentary on breakout stocks and shorts and a Final end of day overall report on breakout stocks for the session, short plays and accumulation plays. There are other features too such as Quick Trades and Long-term Plays.
TTD Daily Report is $39. It covers a Morning slide show of charts of stocks breaking out and a TTD end of day print report covering breakout stocks and shorts.
Credit cards accepted. Payable to Corona Publishing Enterprises.
(The information contained has been prepared from data deemed reliable but there is no guarantee of complete accuracy. Ticker Tape Digest Inc. is not affiliated with any broker, dealer or investment advisor. Nothing in this publication constitutes an offer, recommendation or solicitation to buy or sell any securities. Further research is advised. This report is copyrighted and no redistribution is permitted with out permission.)